Pharmacokinetic (PK) Study of ASP015K -Evaluation of Pharmacokinetics in Patients With Impaired Renal Function and Subjects With Normal Renal Function-
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Peficitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Astellas Pharma
- 03 Jan 2017 Status changed from recruiting to completed.
- 03 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Nov 2015 New trial record